Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Ischemia | 23 | 2017 | 2132 | 1.650 |
Why?
|
Hypercholesterolemia | 9 | 2012 | 1148 | 1.410 |
Why?
|
Stilbenes | 8 | 2013 | 154 | 1.180 |
Why?
|
Surgical Wound Dehiscence | 4 | 2023 | 215 | 1.000 |
Why?
|
Naproxen | 3 | 2011 | 99 | 0.820 |
Why?
|
Myocardium | 16 | 2020 | 4764 | 0.720 |
Why?
|
Coronary Circulation | 10 | 2012 | 1601 | 0.720 |
Why?
|
Sternotomy | 6 | 2023 | 134 | 0.660 |
Why?
|
Alcoholic Beverages | 5 | 2012 | 265 | 0.640 |
Why?
|
Wine | 5 | 2017 | 172 | 0.630 |
Why?
|
Swine | 31 | 2017 | 5986 | 0.620 |
Why?
|
Sternum | 4 | 2023 | 177 | 0.620 |
Why?
|
Neovascularization, Physiologic | 10 | 2014 | 1370 | 0.620 |
Why?
|
Collateral Circulation | 7 | 2012 | 289 | 0.620 |
Why?
|
Carbon Monoxide | 1 | 2021 | 560 | 0.600 |
Why?
|
Surgical Wound Infection | 4 | 2023 | 1544 | 0.570 |
Why?
|
Cardiopulmonary Bypass | 7 | 2022 | 1097 | 0.530 |
Why?
|
Oxidative Stress | 10 | 2020 | 3140 | 0.530 |
Why?
|
Cyclooxygenase Inhibitors | 3 | 2011 | 361 | 0.490 |
Why?
|
Sulfonamides | 4 | 2011 | 1979 | 0.440 |
Why?
|
Myocardial Reperfusion Injury | 3 | 2011 | 480 | 0.420 |
Why?
|
Pyrazoles | 3 | 2011 | 2031 | 0.400 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2011 | 318 | 0.400 |
Why?
|
Swine, Miniature | 16 | 2014 | 972 | 0.400 |
Why?
|
Prostaglandins | 2 | 2011 | 396 | 0.370 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2013 | 3498 | 0.350 |
Why?
|
Apoptosis | 10 | 2020 | 9505 | 0.350 |
Why?
|
Ethanol | 5 | 2017 | 1325 | 0.350 |
Why?
|
Warm Ischemia | 1 | 2010 | 64 | 0.330 |
Why?
|
Heart | 4 | 2012 | 4419 | 0.320 |
Why?
|
Tricuspid Valve | 2 | 2024 | 421 | 0.310 |
Why?
|
Coronary Vessels | 7 | 2012 | 3094 | 0.300 |
Why?
|
Echocardiography, Three-Dimensional | 2 | 2024 | 611 | 0.290 |
Why?
|
Coronary Artery Disease | 8 | 2022 | 6544 | 0.290 |
Why?
|
Thrombin | 1 | 2010 | 601 | 0.290 |
Why?
|
Endothelium | 1 | 2010 | 768 | 0.290 |
Why?
|
Heptanoic Acids | 3 | 2014 | 344 | 0.290 |
Why?
|
Heart Arrest, Induced | 3 | 2013 | 359 | 0.270 |
Why?
|
Organ Preservation | 1 | 2010 | 400 | 0.260 |
Why?
|
Myocardial Revascularization | 3 | 2019 | 795 | 0.260 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4044 | 0.260 |
Why?
|
Angiogenesis Inducing Agents | 3 | 2012 | 254 | 0.260 |
Why?
|
Arterioles | 5 | 2013 | 251 | 0.250 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2023 | 1563 | 0.250 |
Why?
|
Disease Models, Animal | 21 | 2017 | 18292 | 0.230 |
Why?
|
Blood Proteins | 1 | 2010 | 1186 | 0.230 |
Why?
|
Coronary Artery Bypass | 4 | 2022 | 2188 | 0.230 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2010 | 1119 | 0.220 |
Why?
|
Immunoblotting | 5 | 2020 | 1643 | 0.220 |
Why?
|
Diabetes Complications | 1 | 2010 | 1318 | 0.220 |
Why?
|
Dietary Fats | 1 | 2011 | 2002 | 0.220 |
Why?
|
Pyrroles | 3 | 2014 | 1119 | 0.220 |
Why?
|
Cell Survival | 2 | 2010 | 5745 | 0.210 |
Why?
|
Aortic Valve Stenosis | 3 | 2023 | 2022 | 0.210 |
Why?
|
Energy Metabolism | 3 | 2012 | 2894 | 0.210 |
Why?
|
Debridement | 2 | 2022 | 494 | 0.200 |
Why?
|
Heart Valve Diseases | 2 | 2021 | 1029 | 0.200 |
Why?
|
Mitral Valve Insufficiency | 2 | 2022 | 1415 | 0.200 |
Why?
|
Hemodynamics | 5 | 2012 | 4186 | 0.190 |
Why?
|
Thromboxane A2 | 2 | 2011 | 87 | 0.190 |
Why?
|
Muscle, Skeletal | 6 | 2017 | 4959 | 0.190 |
Why?
|
Animals | 38 | 2021 | 168735 | 0.180 |
Why?
|
Cardiotonic Agents | 2 | 2014 | 539 | 0.180 |
Why?
|
Neuropeptide Y | 2 | 2012 | 194 | 0.180 |
Why?
|
RNA | 3 | 2020 | 2716 | 0.180 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2024 | 363 | 0.170 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 2050 | 0.170 |
Why?
|
Microcirculation | 4 | 2012 | 1282 | 0.160 |
Why?
|
Peptide Fragments | 2 | 2020 | 5126 | 0.160 |
Why?
|
Up-Regulation | 3 | 2020 | 4130 | 0.160 |
Why?
|
Random Allocation | 3 | 2017 | 2394 | 0.160 |
Why?
|
Embolectomy | 1 | 2020 | 130 | 0.160 |
Why?
|
Cardiac Surgical Procedures | 3 | 2022 | 3682 | 0.160 |
Why?
|
Receptors, Notch | 2 | 2014 | 751 | 0.160 |
Why?
|
Perfusion | 4 | 2011 | 1408 | 0.160 |
Why?
|
Cyclooxygenase 2 | 2 | 2011 | 594 | 0.150 |
Why?
|
Vena Cava Filters | 2 | 2020 | 270 | 0.150 |
Why?
|
Myocardial Infarction | 4 | 2019 | 11508 | 0.140 |
Why?
|
Signal Transduction | 11 | 2014 | 23597 | 0.140 |
Why?
|
Patient Care Team | 2 | 2020 | 2515 | 0.140 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 462 | 0.140 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2020 | 1481 | 0.140 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2021 | 419 | 0.140 |
Why?
|
Heart Diseases | 3 | 2018 | 2818 | 0.140 |
Why?
|
Metformin | 3 | 2014 | 904 | 0.140 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2019 | 262 | 0.140 |
Why?
|
Intraoperative Care | 1 | 2021 | 768 | 0.140 |
Why?
|
Endothelial Cells | 1 | 2010 | 3586 | 0.140 |
Why?
|
Ventricular Function, Left | 5 | 2012 | 3930 | 0.130 |
Why?
|
Muscle Contraction | 2 | 2011 | 1207 | 0.130 |
Why?
|
Blood Transfusion | 1 | 2022 | 1307 | 0.130 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2010 | 3444 | 0.130 |
Why?
|
Thoracic Surgery | 1 | 2022 | 727 | 0.120 |
Why?
|
Hospital Mortality | 2 | 2020 | 5339 | 0.120 |
Why?
|
Enzyme Induction | 2 | 2012 | 456 | 0.120 |
Why?
|
Pulmonary Embolism | 2 | 2020 | 2596 | 0.120 |
Why?
|
Insulin | 5 | 2012 | 6603 | 0.120 |
Why?
|
Thromboxanes | 2 | 2011 | 45 | 0.120 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2014 | 3249 | 0.120 |
Why?
|
Diabetes Mellitus | 3 | 2020 | 5889 | 0.120 |
Why?
|
Nitric Oxide Synthase Type III | 3 | 2012 | 707 | 0.120 |
Why?
|
Blotting, Western | 5 | 2017 | 5019 | 0.120 |
Why?
|
Male | 41 | 2024 | 363815 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2012 | 2057 | 0.110 |
Why?
|
Lipid Peroxidation | 2 | 2012 | 275 | 0.110 |
Why?
|
Reference Values | 2 | 2011 | 4909 | 0.110 |
Why?
|
Immunohistochemistry | 6 | 2017 | 11030 | 0.110 |
Why?
|
Sus scrofa | 2 | 2012 | 430 | 0.110 |
Why?
|
Heart Function Tests | 2 | 2011 | 317 | 0.110 |
Why?
|
Endothelium, Vascular | 4 | 2012 | 4423 | 0.110 |
Why?
|
Epoprostenol | 2 | 2011 | 246 | 0.110 |
Why?
|
Administration, Oral | 2 | 2011 | 4016 | 0.110 |
Why?
|
Amyloidosis | 1 | 2021 | 883 | 0.110 |
Why?
|
Hypoglycemic Agents | 4 | 2014 | 3106 | 0.100 |
Why?
|
Chemokines | 1 | 2017 | 956 | 0.100 |
Why?
|
Diet, Atherogenic | 1 | 2012 | 92 | 0.100 |
Why?
|
Oxygen | 2 | 2022 | 4246 | 0.100 |
Why?
|
Thrombectomy | 1 | 2017 | 676 | 0.100 |
Why?
|
Caspase 3 | 2 | 2014 | 731 | 0.100 |
Why?
|
Alcohols | 1 | 2012 | 94 | 0.100 |
Why?
|
Interleukins | 1 | 2017 | 789 | 0.100 |
Why?
|
Vasoconstriction | 2 | 2012 | 593 | 0.100 |
Why?
|
Sarcopenia | 1 | 2017 | 378 | 0.100 |
Why?
|
Chymases | 1 | 2011 | 84 | 0.090 |
Why?
|
Humans | 39 | 2024 | 765926 | 0.090 |
Why?
|
Treatment Outcome | 11 | 2023 | 65194 | 0.090 |
Why?
|
Vasodilation | 2 | 2012 | 969 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2023 | 2041 | 0.090 |
Why?
|
Gene Expression Regulation | 5 | 2018 | 11895 | 0.090 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2013 | 1494 | 0.090 |
Why?
|
Autophagy | 2 | 2020 | 1350 | 0.090 |
Why?
|
Vasoconstrictor Agents | 2 | 2011 | 653 | 0.090 |
Why?
|
Pericardium | 2 | 2012 | 679 | 0.090 |
Why?
|
Myocardial Reperfusion | 1 | 2011 | 338 | 0.090 |
Why?
|
Raffinose | 1 | 2010 | 57 | 0.090 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2011 | 174 | 0.080 |
Why?
|
Procaine | 1 | 2010 | 60 | 0.080 |
Why?
|
Female | 24 | 2024 | 396141 | 0.080 |
Why?
|
Atrial Appendage | 1 | 2013 | 284 | 0.080 |
Why?
|
Potassium Chloride | 1 | 2010 | 229 | 0.080 |
Why?
|
Blood Chemical Analysis | 1 | 2011 | 434 | 0.080 |
Why?
|
Mannitol | 1 | 2010 | 176 | 0.080 |
Why?
|
Coronary Angiography | 5 | 2012 | 4498 | 0.080 |
Why?
|
Organ Preservation Solutions | 1 | 2010 | 105 | 0.080 |
Why?
|
Phytotherapy | 1 | 2011 | 296 | 0.080 |
Why?
|
Endothelin-1 | 1 | 2010 | 295 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3801 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14643 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 478 | 0.080 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 414 | 0.080 |
Why?
|
Mitral Valve | 3 | 2022 | 1475 | 0.080 |
Why?
|
Allopurinol | 1 | 2010 | 203 | 0.080 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2012 | 882 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2012 | 2455 | 0.080 |
Why?
|
Angiogenic Proteins | 3 | 2014 | 101 | 0.070 |
Why?
|
Hemorrhage | 1 | 2020 | 3466 | 0.070 |
Why?
|
Aged | 19 | 2024 | 171163 | 0.070 |
Why?
|
Sodium Chloride | 1 | 2010 | 578 | 0.070 |
Why?
|
Cholesterol, Dietary | 3 | 2014 | 224 | 0.070 |
Why?
|
Plant Extracts | 1 | 2011 | 493 | 0.070 |
Why?
|
Echocardiography, Transesophageal | 2 | 2024 | 1093 | 0.070 |
Why?
|
Glutathione | 1 | 2010 | 588 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3615 | 0.070 |
Why?
|
Risk Factors | 6 | 2023 | 74850 | 0.070 |
Why?
|
Models, Cardiovascular | 1 | 2012 | 979 | 0.070 |
Why?
|
Phosphorylation | 3 | 2012 | 8279 | 0.070 |
Why?
|
Erythrocyte Transfusion | 2 | 2022 | 574 | 0.070 |
Why?
|
Myocardial Contraction | 1 | 2011 | 1516 | 0.060 |
Why?
|
Liver | 2 | 2012 | 7559 | 0.060 |
Why?
|
Staining and Labeling | 1 | 2010 | 1072 | 0.060 |
Why?
|
Databases, Factual | 1 | 2021 | 8060 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2012 | 6202 | 0.060 |
Why?
|
Renin-Angiotensin System | 1 | 2010 | 736 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2023 | 81537 | 0.060 |
Why?
|
Adenosine | 1 | 2010 | 813 | 0.060 |
Why?
|
Cryopreservation | 1 | 2010 | 727 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2011 | 2270 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1671 | 0.060 |
Why?
|
Cardiovascular System | 1 | 2011 | 838 | 0.060 |
Why?
|
Neovascularization, Pathologic | 2 | 2014 | 2627 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3606 | 0.050 |
Why?
|
Heart Arrest | 1 | 2013 | 1516 | 0.050 |
Why?
|
Vasodilator Agents | 3 | 2012 | 988 | 0.050 |
Why?
|
Microvessels | 3 | 2012 | 590 | 0.050 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 2 | 2012 | 64 | 0.050 |
Why?
|
Blood Glucose | 3 | 2012 | 6422 | 0.050 |
Why?
|
Anticoagulants | 1 | 2017 | 4856 | 0.050 |
Why?
|
Pectoralis Muscles | 1 | 2022 | 86 | 0.050 |
Why?
|
Middle Aged | 10 | 2024 | 223016 | 0.050 |
Why?
|
Glucose Transporter Type 4 | 2 | 2012 | 241 | 0.050 |
Why?
|
Length of Stay | 3 | 2021 | 6486 | 0.050 |
Why?
|
Insulin Resistance | 2 | 2012 | 3988 | 0.050 |
Why?
|
Aortic Valve | 2 | 2023 | 1964 | 0.050 |
Why?
|
Protein Kinase C-alpha | 2 | 2012 | 112 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2011 | 6306 | 0.050 |
Why?
|
Tissue Adhesions | 2 | 2012 | 222 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9525 | 0.050 |
Why?
|
Lipids | 1 | 2011 | 3317 | 0.040 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2012 | 558 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2014 | 3965 | 0.040 |
Why?
|
Fibrosis | 3 | 2012 | 2073 | 0.040 |
Why?
|
Papillary Muscles | 1 | 2021 | 192 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2879 | 0.040 |
Why?
|
Medicare | 1 | 2018 | 6815 | 0.040 |
Why?
|
Plaque, Atherosclerotic | 1 | 2011 | 1529 | 0.040 |
Why?
|
Liver Function Tests | 2 | 2012 | 527 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2012 | 4041 | 0.040 |
Why?
|
Time | 1 | 2021 | 549 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2013 | 12235 | 0.040 |
Why?
|
Cause of Death | 2 | 2020 | 3715 | 0.040 |
Why?
|
Suture Techniques | 1 | 2023 | 774 | 0.040 |
Why?
|
Independent Living | 1 | 2023 | 583 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11837 | 0.040 |
Why?
|
Glucose | 1 | 2010 | 4335 | 0.040 |
Why?
|
Thrombosis | 1 | 2011 | 2955 | 0.040 |
Why?
|
Chronic Disease | 4 | 2014 | 9351 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20690 | 0.040 |
Why?
|
Inflammation | 3 | 2012 | 10843 | 0.040 |
Why?
|
Coronary Disease | 1 | 2011 | 5919 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 15645 | 0.030 |
Why?
|
Macrophages | 1 | 2011 | 5772 | 0.030 |
Why?
|
Comorbidity | 1 | 2011 | 10575 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1657 | 0.030 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2012 | 669 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2012 | 10727 | 0.030 |
Why?
|
Sex Factors | 2 | 2021 | 10611 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12822 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1276 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2018 | 790 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2020 | 809 | 0.030 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 645 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54807 | 0.030 |
Why?
|
Thorax | 1 | 2017 | 554 | 0.030 |
Why?
|
Heart Ventricles | 2 | 2020 | 3833 | 0.030 |
Why?
|
Ischemia | 1 | 2022 | 1901 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 1 | 2014 | 282 | 0.030 |
Why?
|
Cardioplegic Solutions | 1 | 2013 | 123 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2021 | 1422 | 0.030 |
Why?
|
Radioimmunoprecipitation Assay | 1 | 2012 | 16 | 0.030 |
Why?
|
Protein Kinase C-epsilon | 1 | 2012 | 43 | 0.030 |
Why?
|
Receptors, Neuropeptide Y | 1 | 2012 | 47 | 0.030 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2012 | 87 | 0.030 |
Why?
|
Inflammation Mediators | 2 | 2012 | 1886 | 0.020 |
Why?
|
Thoracic Vertebrae | 1 | 2017 | 614 | 0.020 |
Why?
|
Nitroprusside | 1 | 2012 | 271 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 1 | 2012 | 186 | 0.020 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2012 | 94 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2017 | 1613 | 0.020 |
Why?
|
Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2011 | 10 | 0.020 |
Why?
|
Thromboxane-A Synthase | 1 | 2011 | 34 | 0.020 |
Why?
|
Aorta | 1 | 2019 | 2040 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15878 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2012 | 125 | 0.020 |
Why?
|
Reoperation | 2 | 2012 | 4308 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1735 | 0.020 |
Why?
|
Adenosine Diphosphate | 1 | 2012 | 419 | 0.020 |
Why?
|
Substance P | 1 | 2012 | 331 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2013 | 788 | 0.020 |
Why?
|
PPAR alpha | 1 | 2012 | 177 | 0.020 |
Why?
|
Type C Phospholipases | 1 | 2011 | 284 | 0.020 |
Why?
|
Receptors, Endothelin | 1 | 2010 | 56 | 0.020 |
Why?
|
Angiostatins | 1 | 2010 | 64 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1319 | 0.020 |
Why?
|
Capillaries | 1 | 2013 | 751 | 0.020 |
Why?
|
Muscle Cells | 1 | 2011 | 194 | 0.020 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 484 | 0.020 |
Why?
|
Coronary Artery Bypass, Off-Pump | 1 | 2010 | 65 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2011 | 393 | 0.020 |
Why?
|
Caspases | 1 | 2012 | 880 | 0.020 |
Why?
|
Gene Expression | 2 | 2012 | 7581 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2012 | 595 | 0.020 |
Why?
|
Leptin | 1 | 2017 | 1596 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2013 | 1077 | 0.020 |
Why?
|
Species Specificity | 1 | 2013 | 2406 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2010 | 382 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1150 | 0.020 |
Why?
|
Hematocrit | 1 | 2010 | 622 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2011 | 752 | 0.020 |
Why?
|
Sphingosine | 1 | 2010 | 306 | 0.020 |
Why?
|
Peptides, Cyclic | 1 | 2010 | 390 | 0.020 |
Why?
|
Tyrosine | 1 | 2012 | 1427 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2470 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 1180 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2012 | 1202 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1489 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39228 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2017 | 1878 | 0.020 |
Why?
|
Echocardiography | 1 | 2020 | 5040 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2910 | 0.020 |
Why?
|
Ventricular Fibrillation | 1 | 2010 | 538 | 0.020 |
Why?
|
Thiophenes | 1 | 2011 | 570 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 1623 | 0.020 |
Why?
|
Body Temperature | 1 | 2010 | 781 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12417 | 0.020 |
Why?
|
Time Factors | 3 | 2014 | 40097 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2011 | 896 | 0.020 |
Why?
|
Patient Readmission | 1 | 2020 | 3282 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2012 | 1787 | 0.020 |
Why?
|
Cadherins | 1 | 2010 | 899 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 3583 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1966 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13273 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 1938 | 0.020 |
Why?
|
Mitochondria | 1 | 2018 | 3669 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2219 | 0.010 |
Why?
|
Oligopeptides | 1 | 2010 | 1193 | 0.010 |
Why?
|
Arteries | 1 | 2010 | 1120 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1961 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14745 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8882 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4563 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2627 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2012 | 22228 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2019 | 4305 | 0.010 |
Why?
|
Collagen | 1 | 2012 | 2616 | 0.010 |
Why?
|
Robotics | 1 | 2010 | 807 | 0.010 |
Why?
|
Energy Intake | 1 | 2011 | 2141 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2012 | 2141 | 0.010 |
Why?
|
Regeneration | 1 | 2012 | 1516 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 59496 | 0.010 |
Why?
|
Risk Assessment | 1 | 2023 | 24275 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3796 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2902 | 0.010 |
Why?
|
Piperidines | 1 | 2010 | 1664 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15828 | 0.010 |
Why?
|
Tachycardia, Ventricular | 1 | 2010 | 1313 | 0.010 |
Why?
|
Fibroblasts | 1 | 2011 | 4161 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 2028 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29890 | 0.010 |
Why?
|
United States | 2 | 2019 | 72909 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8107 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2046 | 0.010 |
Why?
|
Pilot Projects | 1 | 2013 | 8724 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4023 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2012 | 36547 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4342 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3851 | 0.010 |
Why?
|
Heart Rate | 1 | 2010 | 4203 | 0.010 |
Why?
|
Risk | 1 | 2011 | 9599 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2011 | 3427 | 0.010 |
Why?
|
Adult | 2 | 2022 | 223088 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13614 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7847 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7417 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10426 | 0.010 |
Why?
|
Rats | 1 | 2011 | 23708 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8530 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9443 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5691 | 0.010 |
Why?
|
Diet | 1 | 2011 | 8087 | 0.010 |
Why?
|
Mice | 1 | 2010 | 81782 | 0.000 |
Why?
|